ProCE Banner Activity

Interactive Decision Support Tool: Expert Treatment Guidance for ITP

Tool

Use this Interactive Decision Support Tool to compare your approach for treating patients with immune thrombocytopenia (ITP) with the strategies recommended by 4 expert hematologists

Released: October 26, 2022

Expiration: October 25, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Rigel Pharmaceuticals Inc

Faculty Disclosure

Contributing Author

Hanny Al-Samkari, MD

Assistant Professor
Harvard Medical School
Attending Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Boston, Massachusetts

Hanny Al-Samkari, MD: consultant/advisor/speaker: Agios, Argenx, Dova/Sobi, Forma, Moderna, Novartis, Rigel; research support: paid to his institution from Agios, Amgen, Dova/Sobi.

Catherine M. Broome, MD

Professor of Medicine
Director of Cellular Apheresis
Lombardi Cancer Center
MedStar Georgetown University
Washington, DC

Catherine M. Broome, MD: consultant/advisor/speaker: Alexion, Incyte, Sanofi; research support: Argenx.

Sandhya Ramanathan Panch, MD, MPH

Associate Professor
Division of Hematology
University of Washington
Medical Director
Transfusion Services
Fred Hutchinson Cancer Center
Seattle, Washington


Kristin Ammon Shimano, MD

Health Sciences Clinical Associate Professor
Department of Pediatrics
UCSF Benioff Childrens Hospital
San Francisco, California